Reconstitution of functional dopamine D(2s) receptor by co-expression of amino- and carboxyl-terminal receptor fragments.
暂无分享,去创建一个
M. Scarselli | G. Corsini | R. Maggio | R Maggio | G U Corsini | S. Chiacchio | M Scarselli | M Armogida | S Chiacchio | M G DeMontis | A Colzi | M. Armogida | A. Colzi | M. Demontis
[1] S. S. Lee,et al. In vivo assembly of rhodopsin from expressed polypeptide fragments. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[2] D. Grandy,et al. Cloning of the cDNA and gene for a human D2 dopamine receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[3] C. Gerfen,et al. Multiple D2 dopamine receptors produced by alternative RNA splicing , 1989, Nature.
[4] J. Wess,et al. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co‐expressed receptor polypeptide. , 1996, The EMBO journal.
[5] T. Schwartz,et al. Split-receptors in the tachykinin neurokinin-1 system--mutational analysis of intracellular loop 3. , 1998, European journal of biochemistry.
[6] C. Londos,et al. A highly sensitive adenylate cyclase assay. , 1974, Analytical biochemistry.
[7] M. Caron,et al. Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. , 1988, Science.
[8] Jie Liu,et al. Plasma Membrane Localization and Functional Rescue of Truncated Forms of a G Protein-coupled Receptor (*) , 1995, The Journal of Biological Chemistry.
[9] D. Engelman,et al. Membrane protein folding and oligomerization: the two-stage model. , 1990, Biochemistry.
[10] J. Wess,et al. Molecular Mechanisms Involved in Muscarinic Acetylcholine Receptor-mediated G Protein Activation Studied by Insertion Mutagenesis (*) , 1996, The Journal of Biological Chemistry.
[11] C Higgs,et al. Domain swapping in G-protein coupled receptor dimers. , 1998, Protein engineering.
[12] P. Seeman,et al. Dopamine D2 receptor dimers and receptor-blocking peptides. , 1996, Biochemical and biophysical research communications.
[13] B. Cullen. Use of eukaryotic expression technology in the functional analysis of cloned genes. , 1987, Methods in enzymology.
[14] B. Sommer,et al. The dopamine D2 receptor: two molecular forms generated by alternative splicing. , 1989, The EMBO journal.
[15] G. Demontis,et al. G protein-linked receptors: pharmacological evidence for the formation of heterodimers. , 1999, The Journal of pharmacology and experimental therapeutics.
[16] P. Sokoloff,et al. Novel dopamine receptors half a decade later. , 1995, Trends in pharmacological sciences.
[17] R. Todd,et al. Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines. , 1994, The Journal of pharmacology and experimental therapeutics.
[18] C. Reynolds,et al. A new approach to docking in the beta 2-adrenergic receptor that exploits the domain structure of G-protein-coupled receptors. , 1997, Journal of medicinal chemistry.
[19] P. Sokoloff,et al. Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors. , 1999, European journal of pharmacology.
[20] P. Seeman,et al. Dopamine D2 receptor dimers in human and rat brain , 1998, FEBS letters.
[21] M. Martres,et al. Alternative splicing directs the expression of two D2 dopamine receptor isoforms , 1989, Nature.
[22] J. Wess,et al. Reconstitution of functional muscarinic receptors by co‐expression of amino‐ and carboxyl‐terminal receptor fragments , 1993, FEBS letters.